Tirzepatide Without Insurance: Options & Costs
Considering tirzepatide without insurance? Learn access options, what providers check, total costs, safety/follow-up, and the key questions to ask first.
Learn safe injection sites and how to rotate them for medications containing tirzepatide (abdomen, thigh, or upper arm). Plus rotation, technique, and storage tips.
Important notice on compounded medications: Compounded medications are not FDA-approved and may be prescribed only when a licensed prescriber determines a clinically significant difference for an identified patient. These medications are not reviewed by the FDA for safety, efficacy, or quality. Eden coordinates care; licensed providers evaluate and prescribe; partner pharmacies dispense and label.
In this guide, we’ll walk through the basics of properly injecting tirzepatide, covering common subcutaneous sites, rotation, timing, and safe handling. Per FDA-approved labeling for Mounjaro® and Zepbound®, inject tirzepatide subcutaneously into the abdomen, thigh, or have another person inject the back of your upper arm. Each location offers practical advantages for safe medication delivery and weekly self-care.
Inject into the fatty layer just beneath the skin, not into muscle like many vaccines. The sections below explain site selection, technique, and rotation.
Use the fleshy area on the back of the upper arm in the triceps region. Have another person inject this area and avoid muscle.
Placement tips (upper arm):
The abdomen is generally the most popular injection site for tirzepatide. Place your injection at least two inches away from your navel.
Tip: Use the large surface area to rotate spots and avoid irritated or scarred skin.
Your thigh is another excellent option. Target the front or outer portions of your thighs where there’s enough fatty tissue.
Some patients experience discomfort with thigh injections. Choose a fleshy area free of scars or bruises and keep rotating locations over time.
You should alternate between injection sites weekly to prevent skin irritation, reduce the risk of infection, avoid the development of fatty lumps, and help maintain consistent absorption.
{{primary-cta}}
Gather supplies: your tirzepatide pen (or vial/syringe if prescribed), alcohol swabs, clean gauze/cotton, and a sharps container.
Clean: Wash hands with soap and warm water. Check the solution (clear to slightly yellow, with no particles) and verify the expiration date.
Prep the skin: Clean with an alcohol swab and allow to air-dry completely. Do not touch or blow on the site.
Do not throw loose needles, syringes, or pens in household trash or recycling. Place them in an FDA-cleared sharps container and follow your local disposal rules.
Missed dose: Follow the missed-dose instructions in your product labeling or contact your clinician.
Rotate consistently (a different spot within the same general area each week) to help avoid tissue changes that can affect absorption.
Avoid these mistakes:
Do not adjust your dose without medical guidance. Incorrect dosing can cause serious side effects (e.g., severe nausea/vomiting, hypoglycemia, etc.).
Pro tip: Keep a simple log of dates and locations to make rotation effortless.
{{primary-cta}}
Tirzepatide may cause side effects, most commonly gastrointestinal symptoms (nausea, vomiting, diarrhea, decreased appetite), with rarer but serious risks discussed below; review these with your provider.
For dosing concerns or a potential overdose, contact your healthcare provider or Poison Control (1-800-222-1222).
Your tirzepatide needs proper storage to maintain its effectiveness. Unused pens or vials require refrigeration between 36°F-46°F (2°C-8°C) until the printed expiration date. Keep the medication in its original carton to protect it from light.
Understanding the differences between FDA-approved tirzepatide and compounded versions is important for your treatment safety. FDA-approved tirzepatide products (Mounjaro®, Zepbound®) have been reviewed for safety, effectiveness, and quality. Compounded tirzepatide is not FDA-approved and may vary in formulation and potency; it may be prescribed only when clinically appropriate for an identified patient.
Proper tirzepatide administration comes down to choosing an appropriate site (abdomen, thigh, or, by another person, on the back of the upper arm), using proper technique, and rotating weekly. Follow your product’s Instructions for Use and your clinician’s guidance. Watch for concerning symptoms and store your medication correctly. When available and appropriate, FDA-approved products are recommended.
Curious about oral tirzepatide? Check out our blog covering oral tirzepatide availability.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
All label-supported sites (abdomen, thigh, and back of the upper arm) are suitable for subcutaneous tirzepatide. Rotate sites weekly. If using the upper arm, have another person give the injection.
Yes. Use the front or outer thigh where there is sufficient fatty tissue. It’s accessible when sitting and offers room for rotation.
Yes. Inject at least 2 inches (5 cm) away from the navel, and rotate sites each week.
Use a different spot each week within the same general area (abdomen, thigh, or upper arm). A simple log helps ensure consistent rotation.
Refrigerate at 36–46°F (2–8°C) and protect from light. You may store a pen at room temperature up to 86°F (30°C) for up to 21 days (check your product’s instructions for use). Do not freeze.
Eli Lilly and Company. (2022). HIGHLIGHTS OF PRESCRIBING INFORMATION. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
Frías, J. P., Davies, M. J., Rosenstock, J., Manghi, F. C. P., Landó, L. F., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/nejmoa2107519
HIGHLIGHTS OF PRESCRIBING INFORMATION. (2023). [Prescribing information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/nejmoa2206038
Lilly USA, LLC. (2023). INSTRUCTIONS FOR USE. https://pi.lilly.com/us/zepbound-pen-us-ifu.pdf
Lilly USA, LLC. (2024). INSTRUCTIONS FOR USE. https://pi.lilly.com/us/mounjaro-us-ifu.pdf
Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Eden is not affiliated with or endorsed by Eli Lilly and Company.